KLDO — Kaleido Biosciences Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.09m
- -$16.69m
- $1.10m
Annual cashflow statement for Kaleido Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -27.6 | -61.7 | -86.3 | -81.6 | -90.3 |
| Depreciation | |||||
| Non-Cash Items | 0.738 | 8.14 | 10.4 | 13.7 | 11.1 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 4.01 | 6.5 | -1.22 | 4.55 | -0.263 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -22.5 | -46.3 | -75.8 | -61.5 | -77.1 |
| Capital Expenditures | -1.41 | -3 | -3.59 | -4.02 | -1.13 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | — | 0.438 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1.41 | -3 | -3.59 | -4.02 | -0.691 |
| Financing Cash Flow Items | 0 | -1.84 | -1.16 | -0.079 | -0.359 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 49.7 | 98.9 | 74.6 | 40.4 | 70 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 25.8 | 49.6 | -4.74 | -25.1 | -7.75 |